Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009906
Filing Date
2022-05-16
Accepted
2022-05-13 20:35:40
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q revb-20220331.htm   iXBRL 10-Q 1802868
2 EX-31.1 revb-ex31_1.htm EX-31.1 40256
3 EX-31.2 revb-ex31_2.htm EX-31.2 40316
4 EX-32.1 revb-ex32_1.htm EX-32.1 14618
5 EX-32.2 revb-ex32_2.htm EX-32.2 15483
  Complete submission text file 0000950170-22-009906.txt   6588996

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT revb-20220331.xsd EX-101.SCH 56928
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT revb-20220331_def.xml EX-101.DEF 262711
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT revb-20220331_pre.xml EX-101.PRE 356415
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT revb-20220331_lab.xml EX-101.LAB 431819
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT revb-20220331_cal.xml EX-101.CAL 30456
55 EXTRACTED XBRL INSTANCE DOCUMENT revb-20220331_htm.xml XML 842640
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39603 | Film No.: 22924910
SIC: 2834 Pharmaceutical Preparations